Skip to main content
Veterinary Medicines

Linspec 50/100 mg/ml Solution for injection for dogs, cats, pigs and pre-ruminant calves

Not authorised
  • Lincomycin hydrochloride
  • Spectinomycin sulfate tetrahydrate

Product identification

Medicine name:
Linspec 50/100 mg/ml Solution for injection for dogs, cats, pigs and pre-ruminant calves
LINSPEC 50/100 MG/ML SOLUTION INJECTABLE POUR CHIENS CHATS PORCINS ET VEAUX PRE-RUMINANTS
Active substance:
  • Lincomycin hydrochloride
  • Spectinomycin sulfate tetrahydrate
Target species:
  • Cattle
  • Dog
  • Cat
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Lincomycin hydrochloride
    54.49
    milligram(s)
    /
    1.00
    millilitre(s)
  • Spectinomycin sulfate tetrahydrate
    151.20
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        21
        day
    • Pig
      • Meat and offal
        14
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF52
Authorisation status:
  • Surrendered
Authorised in:
  • France
Package description:
  • 250 ml multi-dose translucent polypropylene vial with bromobutyl stopper and aluminium cap with a flip off seal. Vials is placed in an outer container (paper box).
  • 100 ml multi-dose translucent polypropylene vial with bromobutyl stopper and aluminium cap with a flip off seal. Vial is placed in an outer container (paper box).

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Cenavisa S.L.
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/4226186 9/2010
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0238/001

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
French (PDF)
Published on: 4/04/2022